Intensive care management of Guillain-Barre syndrome: A retrospective outcome study and review of literature

Abstract

Introduction: Guillain-Barre syndrome (GBS) is an immune mediated disorder which is associated with demyelination of peripheral nervous system and progressive muscle weakness. Severely affected patients have respiratory dysfunction and may need ventilatory support which can cause significant morbidity and mortality. There is limited Indian data with regards to the outcome of severely affected GBS patients. The present study reflects the intensive care management of severely affected GBS patients at neurological centre of a tertiary care institute of India. Materials and Methods: The study was designed to retrospectively review the patient records who were admitted to neurological intensive care unit (ICU) of AIIMS, New Delhi. The epidemiology, clinical features, course of management and outcome of GBS patients admitted between April 2000 to December 2005 were recorded and analysed. Results: The data of 59 patients were available for inclusion in the study. The mean age of patients admitted to neurological ICU was 35 years with male preponderance. Ventilatory failure was the most common indication for ICU admission. 95% patients required ventilatory support for a mean duration of 30 days. The mortality data included 60 patients and 13 patients died during the course of management. Conclusions: The present study indicates that severely affected GBS patients may need prolonged mechanical ventilation. Despite management in a specialized neurological ICU the mortality can be as high as 21%.

Keywords

Critical care - Guillain-Barre syndrome - management

• REFERENCES

• 1 Hund EF, Borel CO, Cornblath DR, Hanley DF, McKhann GM. Intensive management and treatment of severe Guillain-Barré syndrome. Crit Care Med 1993; 21: 433-46
• 2 Asbury AK. Guillain-Barré syndrome: Historical aspects. Ann Neurol 1990; 27 Suppl S2-6
• 3 Schott B. History of Guillain-Barré syndrome. Rev Neurol (Paris) 1982; 138: 931-8
• 4 Alter M. The epidemiology of Guillain-Barré syndrome. Ann Neurol 1990; 27 Suppl S7-12
• 5 Shields WR, Wilbourn J. Demyelinating disorders of the peripheral nervous system. In: Coetz CG. editor. Textbook of Clinical Neurology. 2nd ed.. Philadelphia: Saunders; 2003. p. 1085-100
• 6 Hartung HP, Heininger K, Schäfer B, Fierz W, Toyka KV. Immune mechanisms in inflammatory polyneuropathy. Ann N Y Acad Sci 1988; 540: 122-61
• 7 Feasby TE, Gilbert JJ, Brown WF, Bolton CF, Hahn AF, Koopman WF. et al. An acute axonal form of Guillain-Barré polyneuropathy. Brain 1986; 109: 1115-26
• 8 Asbury AK, Cornblath DR. Assessment of current diagnostic criteria for Guillain-Barré syndrome. Ann Neurol 1990; 27 Suppl S21-4
• 9 McKhann GM. Guillain-Barré syndrome: Clinical and therapeutic observations. Ann Neurol 1990; 27 Suppl S13-6
• 10 Zifko UA. Intensive care and critical illness related neuromuscular disorders: Ventilatory disorders. In: Brown WF, Botton CF, Aminoff MJ. editors. Neuromuscular Function and Disease. Vol. 2. Philadelphia: WB Saunders; 2002. p. 1524-5
• 11 Ng KK, Howard RS, Fish DR, Hirsch NP, Wiles CM, Murray NM. et al. Management and outcome of severe Guillain-Barré syndrome. Q J Med 1995; 88: 243-50
• 12 Hughes RA. Guillain-Barre Syndrome. London: Springer Verag; 1990
• 13 Winer JB, Hughes RA, Osmond C. A prospective study of acute idiopathic neuropathy. Clinical features and their prognostic value. J Neurol Neurosurg Psychiatry 1988; 51: 605-12
• 14 Ropper AH. Severe acute Guillain-Barré syndrome. Neurology 1986; 36: 429-32
• 15 Wijdicks EF, Ropper AH. Acute relapsing Guillain-Barré syndrome after long asymptomatic intervals. Arch Neurol 1990; 47: 82-4
• 16 Ropper AH, Wijdicks EF, Traux BT. Guillain-Barre Syndrome. Philadelphia: FA Davis; 1991
• 17 Laboratory values of clinical importance. In: Isselbacher KJ, Braunwald E, Wilson JD, Martin JB, Fauci AS, Kasper DL. editors. Harrison's Principles of Internal Medicine. 13th ed.. Vol. 2. New York: McGraw-Hill; 1994. p. 2489-96
• 18 Hughes RA, Rees JH. Clinical and epidemiologic features of Guillain-Barré syndrome. J Infect Dis 1997; 176 Suppl (Suppl. 02) S92-8
• 19 Gorthi SP, Kapoor L, Chaudhry R, Sharma N, Perez-Perez GI, Panigrahi P. et al. Guillain-Barré syndrome: Association with Campylobacter jejuni and Mycoplasma pneumoniae infections in India. Nat Med J India 2006; 19: 137-9
• 20 Ravi V, Taly AB, Shankar SK, Shenoy PK, Desai A, Nagaraja D. et al. Association of Japanese encephalitis virus infection with Guillain-Barré syndrome in endemic areas of South India. Acta Neurol Scand 1994; 90: 67-72
• 21 Hughes RA, Cornblath DR. Guillain-Barré syndrome. Lancet 2005; 366: 1653-66
• 22 Fisher M. An unusual variant of acute idiopathic polyneuritis (syndrome of ophthalmoplegia, ataxia and areflexia). N Engl J Med 1956; 255: 57-65
• 23 Kuwabara S. Guillain-Barré syndrome: Epidemiology, pathophysiology and management. Drugs 2004; 64: 597-610
• 24 Winer JB, Hughes RA, Anderson MJ, Jones DM, Kangro H, Watkins RP. A prospective study of acute idiopathic neuropathy. II. Antecedent events. J Neurol Neurosurg Psychiatry 1988; 51: 613-8
• 25 Dowling PC, Cook SD. Role of infection in Guillain-Barré syndrome: Laboratory confirmation of herpesviruses in 41 cases. Ann Neurol 1981; 9 Suppl 44-55
• 26 Dowling P, Menonna J, Cook SD. Cytomegalovirus complement fixation antibody in Guillain-Barré syndrome. Neurology 1977; 27: 1153-6
• 27 Melnick SC, Flewett TH. Role of infection in the Guillain-Barr'e syndrome. J Neurol Neurosurg Psychiatry 1964; 27: 395-407
• 28 Asbury AK, Arnason BG, Karp HR, McFarlin DE. Criteria for diagnosis of Guillain-Barre syndrome. Ann Neurol 1978; 3: 565-6
• 29 Randomised trial of plasma exchange, intravenous immunoglobulin, and combined treatments in Guillain-Barré syndrome. Plasma Exchange/Sandoglobulin Guillain-Barré Syndrome Trial Group. Lancet 1997; 349: 225-30
• 30 Dalakas MC. Mechanisms of action of IVIg and therapeutic considerations in the treatment of acute and chronic demyelinating neuropathies. Neurology 2002; 59: S13-21
• 31 Double-blind trial of intravenous methylprednisolone in Guillain-Barré syndrome. Guillain-Barré syndrome steroid trial group. Lancet 1993; 341: 586-90
• 32 Hughes RA, Swan AV, van Koningsveld R, van Doorn PA. Corticosteroids for Guillain-Barré syndrome. Cochrane Database Syst Rev 2006; 19
• 33 Wollinsky KH, Hülser PJ, Brinkmeier H, Aulkemeyer P, Bössenecker W, Huber-Hartmann KH. et al. CSF filtration is an effective treatment of Guillain-Barré syndrome: A randomized clinical trial. Neurology 2001; 57: 774-80
• 34 Schaller B, Radziwill AJ, Steck AJ. Successful treatment of Guillain-Barré syndrome with combined administration of interferon-beta-1a and intravenous immunoglobulin. Eur Neurol 2001; 46: 167-8
• 35 Miyamoto K, Oka N, Kawasaki T, Miyake S, Yamamura T, Akiguchi I. New cyclooxygenase-2 inhibitors for treatment of experimental autoimmune neuritis. Muscle Nerve 2002; 25: 280-2
• 36 Zochodne DW. Autonomic involvement in Guillain-Barré syndrome: A review. Muscle Nerve 1994; 17: 1145-55
• 37 Ropper AH. Intensive care of acute Guillain-Barré syndrome. Can J Neurol Sci 1994; 21: S23-7
• 38 Traux BT. Autonomic disturbances in Guillain-Barre syndrome. Semin Neurol 1984; 4: 462-8
• 39 Henschel EO. The Guillain-Barré syndrome, a personal experience. Anesthesiology 1977; 47: 228-31
• 40 Ropper AH, Shahani BT. Pain in Guillain-Barré syndrome. Arch Neurol 1984; 41: 511-4
• 41 Goldman LS, Kimball CP. Depression in intensive care units. Int J Psychiatry Med 1987; 17: 201-12
• 42 Gracey DR, McMichan JC, Divertie MB, Howard Jr. FM. Respiratory failure in Guillain-Barré syndrome: A 6-year experience. Mayo Clin Proc 1982; 57: 742-6
• 43 Sunderrajan EV, Davenport J. The Guillain-Barré syndrome: Pulmonary-neurologic correlations. Medicine (Baltimore) 1985; 64: 333-41
• 44 Miller RG, Peterson GW, Daube JR, Albers JW. Prognostic value of electrodiagnosis in Guillain-Barré syndrome. Muscle Nerve 1988; 11: 769-74
• 45 Ropper AH. The Guillain-Barré syndrome. N Engl J Med 1992; 326: 1130-6
• 46 Hughes RA, Winer JB. Guillain-Barre syndrome. In: Mathews WB, Glaser GH. editors. Recent Advances in Clinical Neurology. Edinburg: Churchill Livingstone; 1984. p. 19-49
• 47 Winer JB, Hughes RA. Identification of patients at risk of arrhythmia in the Guillain-Barré syndrome. Q J Med 1988; 68: 735-9
• 48 Lichtenfeld P. Autonomic dysfunction in the Guillain-Barré syndrome. Am J Med 1971; 50: 772-80